Amiloride as an Alternate Adjuvant Antiproteinuric Agent in Fabry Disease: The Potential Roles of Plasmin and uPAR.
about
Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease.Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy.Podocyturia: A Clue for the Rational Use of Amiloride in Alport Renal Disease.Recent Treatment Advances and New Trials in Adult Nephrotic Syndrome.Copious Podocyturia without Proteinuria and with Normal Renal Function in a Young Adult with Fabry Disease.In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
P2860
Amiloride as an Alternate Adjuvant Antiproteinuric Agent in Fabry Disease: The Potential Roles of Plasmin and uPAR.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Amiloride as an Alternate Adju ...... ial Roles of Plasmin and uPAR.
@ast
Amiloride as an Alternate Adju ...... ial Roles of Plasmin and uPAR.
@en
type
label
Amiloride as an Alternate Adju ...... ial Roles of Plasmin and uPAR.
@ast
Amiloride as an Alternate Adju ...... ial Roles of Plasmin and uPAR.
@en
prefLabel
Amiloride as an Alternate Adju ...... ial Roles of Plasmin and uPAR.
@ast
Amiloride as an Alternate Adju ...... ial Roles of Plasmin and uPAR.
@en
P2093
P2860
P356
P1476
Amiloride as an Alternate Adju ...... ial Roles of Plasmin and uPAR.
@en
P2093
H Trimarchi
M Forrester
V Pomeranz
P2860
P304
P356
10.1155/2014/854521
P577
2014-05-15T00:00:00Z